Focal Segmental Glomerulosclerosis
📧 Sign up to get email alerts when something new happens for Focal Segmental Glomerulosclerosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-05-06Clinical Trial Update: Rituximab Treatment of Focal Segmental Glomerulosclerosis [Phase 2]
Phase 2 trial of rituximab for focal segmental glomerulosclerosis has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2021-08-30Clinical Trial Update: Acthar for Treatment of Post-transplant FSGS [Phase 4]
Phase 4 trial of Acthar for post-transplant focal segmental glomerulosclerosis was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-07Clinical Trial Update: Effect of Galactose on Permeblity Factor in Patients With FSGS and CKD Stage 5 [Phase 1]
A Phase 1 trial investigating the effect of galactose on a permeability factor in patients with Focal Segmental Glomerulosclerosis and Chron…
-
CLINICAL_TRIALS withdrawal · 2012-02-09Clinical Trial Update: Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis [NA]
The clinical trial evaluating tacrolimus for idiopathic focal segmental glomerulosclerosis has been withdrawn. Sponsor: Nanjing University S…